(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal

Catalog No. :
ACIGFC892
CAS No. :
28072-80-2
Molecular Formula :
C12H22O11
Molecular Weight :
342.30

IUPAC Name:(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal

(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$314.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal
IUPAC Name(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal
Molecular FormulaC12H22O11
Molecular Weight342.30
SMILESO=C[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)[C@H](O)CO
InChI KeyDKXNBNKWCZZMJT-GFRRCQKTSA-N
SynonymBETA-D-GLUCOPYRANOSYL(1-4)-D-GLUCOPYRANOSE | 4-O-beta-D-Glucopyranosyl-D-glucose | D-Glucose, 4-O-beta-D-glucopyranosyl- | 1-beta-D-Glucopyranosyl-4-D-glucopyranose | beta-D-glucopyranosyl-(1->4)-D-glucopyranose | cellobiose | D-(+)-Cellose | D-celiobiose
CAS No.28072-80-2
PubChem CID439178

Synthetic Route by SureRoute

1. ACIGFC892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIGFC892 route product structure diagram
    ACIGFC89228072-80-2
Inquiry

2. ACIGFC892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIGFC892 route product structure diagram
    ACIGFC89228072-80-2
Inquiry

Comments (0)